Six areas at the frontier of clinical brain research.
We combine clinical neuroscience with rigorous quantitative methods, from predicting and preventing epilepsy after brain injury to measuring how seizures change the brain. Three clinical questions, three methodological strengths, deeply interconnected.
Acquired Epilepsy & Epileptogenesis
Predicting and preventing epilepsy after stroke and other brain injuries.
ExploreSeizures and Dementia
Seizures as an early sign of neurodegeneration, and a target to protect the brain.
ExploreDo Seizures Damage the Brain?
From slow atrophy in chronic epilepsy to rapid injury in status epilepticus.
ExploreBig Data & Causal Inference
Emulating the trials we cannot run, on some of the world’s largest health datasets.
ExplorePrognostic Modelling & Clinical Tools
Validated risk models, turned into calculators and apps that clinicians use.
ExploreQuantitative Neuroimaging
Turning brain scans into numbers that change clinical decisions.
ExploreThe networks and studies we lead.
Much of our work runs on collaboration at scale. We build and lead consortia and multicentre studies, and most actively welcome new partners.
The largest research network dedicated to seizures after stroke, spanning more than 20 cohorts across four continents.
select-consortium.com
Our prospective, biomarker-rich, trial-ready study of seizures after stroke, open to new sites.
Explore the study IMPOSEMulticentre imaging of brain injury during status epilepticus, led from Zurich and inviting centres.
[email protected] ENIGMA-EpilepsyWe lead the longitudinal-imaging analysis within the largest multicentre imaging consortium in epilepsy.
ENIGMA-Epilepsy